Chlamydia News and Research

Latest Chlamydia News and Research

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

Emergent BioSolutions Inc. announced today that it was awarded a cooperative agreement from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to further the development of one of Emergent’s advanced anthrax vaccine candidates known as dmPA7909.

30 Sep 2009

NIAID awards Antigen Discovery a Phase II STTR grant for Chlamydia vaccine development

Antigen Discovery, Inc. ("ADi", formerly ImmPORT Therapeutics, Inc.), a leading biotech company in high throughput antigen and biomarker discovery, announced today that the Company was awarded a Phase II STTR from the National Institute of Allergy and Infectious Diseases (NIAID) under the American Recovery and Reinvestment Act (ARRA) of 2009.

21 Sep 2009

Quidel's updates information on its Influenza A+B test package insert

Quidel Corporation, a global leader in point-of-care (POC) rapid diagnostic tests, issues clarification regarding the Special 510(k) clearance for an update to the Company's QuickVue Influenza A+B test package insert.

19 Sep 2009

Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update

Quidel Corporation (NASDAQ: QDEL), a global leader in point-of-care (POC) rapid diagnostic tests, received Special 510(k) clearance for an update to the Company's QuickVue® Influenza A+B test package insert to include reactivity with culture isolates of the 2009 H1N1 Influenza A virus.

17 Sep 2009

Clinical data emphasizing on efficacy and potency of torezolid to be presented

Trius Therapeutics, Inc. announced today that 13 posters will be presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) supporting the potency, efficacy and safety of torezolid as a potential new antibiotic for the treatment of severe skin infections caused by gram positive bacteria including MRSA.

14 Sep 2009

Quidel Corporation expects highest quarterly revenue due to brisk sales of flu tests

Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid point-of-care diagnostic tests, announced today that it currently anticipates its highest quarterly revenue and operating income in its history, driven by global shipments of its QuickVue® Influenza A+B tests in the third quarter of 2009.

11 Sep 2009

Condoms reduce risk of herpes simplex virus 2

Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

2 Sep 2009

Eye disease medication lowers death rate among Ethiopian children

Children in Ethiopia who received the antibiotic azithromycin as a method for controlling the contagious eye disease trachoma had a lower odds of death compared to children who did not receive the antibiotic, according to a study in the September 2 issue of JAMA.

2 Sep 2009

Solomon Islands could see increase in HIV cases, WHO says

A recent estimate from the World Health Organization says that the number of HIV cases in the Solomon Islands could reach at least 350 by 2010, the Solomon Star News reports.

27 May 2009

New insights into a new strain of chlamydia

New sequencing and analysis of six strains Chlamydia will result in improved diagnosis of the sexually transmitted infection. This study provides remarkable insights into a new strain of Chlamydia that was identified in Sweden in 2006 after spreading rapidly across the country by evading most established diagnostic tests.

20 May 2009

Rates of sexually transmitted infections in Allegheny County, Pa., disproportionately high among blacks, officials say

Health officials in Allegheny County, Pa., on Wednesday held a sexually transmitted infection diversity conference to discuss the disproportionately higher STI rates among blacks and strategies to reduce them, the Pittsburgh Post-Gazette reports.

15 May 2009

Predominant risk factors for first urinary tract infections in college-aged women

Increased sexual activity and alcohol consumption were associated with an increased risk of developing urinary tract infections (UTIs), and college-aged women experiencing urinary frequency or urgency should seek medical care to treat what may be their first urinary tract infection (UTI), according to new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA)

26 Apr 2009

Self-collection of samples in sex workers works best when screening for STIs

Researchers at the University of Westminster have used a simple and convenient method for screening female commercial sex workers (CSW) for sexually transmitted infections (STIs) without the need for them to attend clinics.

1 Apr 2009

Illinois County reports increased STI testing demand

Health Officials in Kane County, Ill., are reporting an increased demand for sexually transmitted infection tests, and the county likely will have to allocate an additional $55,000 to meet the demand, the Chicago Daily Herald reports.

30 Mar 2009

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals, Inc. has announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

26 Mar 2009

Discrimination against Jamaican HIV-positive MSM hinders efforts to seek health care

Men who have sex with men in Jamaica continue to experience difficulty in seeking health care because of discrimination and a law that criminalizes homosexuality, the Jamaica Gleaner reports.

16 Mar 2009

Inadequacy of current guidelines for STIs

Adolescent girls reveal alarmingly high rates of sexually transmitted infections (STIs) which remain largely undetected by recommended screening guidelines.

11 Mar 2009

Experimental microbicide containing natural compound provides protection in monkeys against simian version of HIV

An experimental microbicide containing a naturally occurring compound provides protection in monkeys against the simian version of HIV by diminishing immune responses to the virus, according to a study published Wednesday in the journal Nature, the Los Angeles Times reports.

5 Mar 2009

Inexperienced sex workers most at risk of sexual infections

Less experienced prostitutes are more likely to have sexually transmitted infections (STIs).

12 Dec 2008

Rapid HIV testing in the emergency department boosts diagnoses, screening

One in every 50 people screened for a suspected sexually transmitted infection (STI) in the Emergency Department at Henry Ford Hospital was found to be infected with HIV using a rapid blood sample screening test.

26 Oct 2008

Chlamydia News and Research

Latest Chlamydia News and Research

Emergent BioSolutions receives NIAID funding support for dmPA7909 anthrax vaccine candidate

NIAID awards Antigen Discovery a Phase II STTR grant for Chlamydia vaccine development

Quidel's updates information on its Influenza A+B test package insert

Quidel's QuickVue Influenza A+B test receives special 510(k) clearance for H1N1 reactivity update

Clinical data emphasizing on efficacy and potency of torezolid to be presented

Quidel Corporation expects highest quarterly revenue due to brisk sales of flu tests

Condoms reduce risk of herpes simplex virus 2

Eye disease medication lowers death rate among Ethiopian children

Solomon Islands could see increase in HIV cases, WHO says

New insights into a new strain of chlamydia

Rates of sexually transmitted infections in Allegheny County, Pa., disproportionately high among blacks, officials say

Predominant risk factors for first urinary tract infections in college-aged women

Self-collection of samples in sex workers works best when screening for STIs

Illinois County reports increased STI testing demand

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Discrimination against Jamaican HIV-positive MSM hinders efforts to seek health care

Inadequacy of current guidelines for STIs

Experimental microbicide containing natural compound provides protection in monkeys against simian version of HIV

Inexperienced sex workers most at risk of sexual infections

Rapid HIV testing in the emergency department boosts diagnoses, screening

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Chlamydia News and Research

Latest Chlamydia News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in